tirzepatide supreme court Judge says compounding pharmacies must stop making copies of Zepbound, Mounjaro Eli Lilly Gets FDA Approval

Pediatr Res 19 : 13181321 Fink JK, Brouwers P, Barton N, Malekzadeh MH, Sato S, Hill S, Cohen WE, Fivush B, Gahl WA 1989 Neurologic complications in long-standing nephropathic cystinosis

Rapid weight loss can raise the risk of gallstones or gallbladder inflammation in some people

The double-blinded, randomized control trial enrolled 72 adults with a BMI of 30 or higher who use automated insulin delivery systems to manage their type 1 diabetes

At present, no dedicated evidence-based eligibility thresholds exist for athletes participating in pharmacologically enhanced competitions

Average weight loss percentages guide expectations